Evolent working with adviser on sale after interest, Reuters says

Evolent Health (EVH) is in talks with private equity firms and other companies for a potential sale after the company received inbound interest, Milana Vinn and Anirban Sen of Reuters report, citing people familiar with the matter. Private equity firms TPG (TPG) and KKR (KKR.N) are among the parties that have expressed interest in a deal for Evolent, sources told Reuters. Elevance Health (ELV) is also among the bidders and could team up with a private equity firm to acquire Evolent, the sources added. Evolent is working with a financial adviser on the sale process and has received initial bids, the people said. Shares of Evolent Health are up 11% to $31.10 following the report.